Xin Xiu Sam

Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2

Lian Dee Ler, Sujoy Ghosh, Xiaoran Chai et al. · Science Translational Medicine · 2017 · 211 citations

Medicine, Molecular Biology, Oncology +12

Regulatory crosstalk between lineage-survival oncogenes <i>KLF5, GATA4</i> and <i>GATA6</i> cooperatively promotes gastric cancer development

Na‐Yu Chia, Niantao Deng, Kakoli Das et al. · Gut · 2014 · 172 citations

Medicine, Cancer Biology, Oncology +17

<i>SETD2</i> histone modifier loss in aggressive GI stromal tumours

Kie Kyon Huang, John R. McPherson, Su Ting Tay et al. · Gut · 2015 · 65 citations

Life Sciences, Genetics, Oncology +17

Bizarre giant cells in human angiosarcoma exhibit chemoresistance and contribute to poor survival outcomes

Grace Fangmin Tan, Shane Goh, Abner Herbert Lim et al. · Cancer Science · 2020 · 14 citations · Full text

Medicine, Cell Biology, Oncology +17

Soft Tissue Leiomyosarcoma With Microsatellite Instability, High Tumor Mutational Burden, and Programmed Death Ligand-1 Expression Showing Pathologic Complete Response to Pembrolizumab: A Case Report

Timothy Kwang Yong Tay, Joe Yeong, Eileen Xueqin Chen et al. · JCO Precision Oncology · 2022 · 14 citations · Full text

Medicine, Oncology, Pathology +17